|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 471/04 | |
| C07K 16/44 |
| (11) | Number of the document | 2888263 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13753972.2 |
| Date of filing the European patent application | 2013-08-20 | |
| (97) | Date of publication of the European application | 2015-07-01 |
| (45) | Date of publication and mention of the grant of the patent | 2018-05-09 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2013/055729 |
| Date | 2013-08-20 |
| (87) | Number | WO 2014/031601 |
| Date | 2014-02-27 |
| (30) | Number | Date | Country code |
| 201261691469 P | 2012-08-21 | US |
| (72) |
HASPESLAGH, Pieter Rik, BE
VLIEGEN, Maarten, BE
HRYHORENKO, Eric, US
DECORY, Thomas R., US
SANKARAN, Banumathi, US
|
| (73) |
Janssen Pharmaceutica NV,
Turnhoutseweg 30, 2340 Beerse,
BE
|
| (54) | HAPTENS OF RISPERIDONE AND PALIPERIDONE |
| HAPTENS OF RISPERIDONE AND PALIPERIDONE |